Kindmark, H. et al. 2010. Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®). Acta Oncologica. 49, 1 (Jan. 2010), 100–101. DOI:https://doi.org/10.3109/02841860902897707.